For laboratory research use only Not for human consumption
NobelPepLab

Shop by research area

Metabolic & Weight Research11 Growth Hormone & Endocrine9 Repair, Recovery & Immune7 Skin, Hair & Cosmetic8 Cognitive, Mood & Neuro7 Cellular, Longevity & Mitochondrial5 Lab Supplies1 Vitamin & Amino Blends3

More

Wholesale & bulk
Quality & COAs
Learn
Help: delivery, tracking, returns
Message Us on WhatsApp
Metabolic & Weight Research In stock · dispatched in 1–2 working days

Cagrilintide + Semaglutide (CagriSema) Peptide Vials

Research blend: cagrilintide and semaglutide co-lyophilised in one vial at a 1:1 ratio · boxes of 10 vials

$99.25 £74.36 per box of 10 vials
$9.93 per vial · £7.44
$137.85 £103.28 per box of 10 vials
$13.79 per vial · £10.33
$160.81 £120.48 per box of 10 vials
$16.08 per vial · £12.05

Free delivery worldwide on orders over $1,000 (about £749)

Strength 3 options · price per box

Boxes

5% off at 10+ boxes (any mix, bac water not counted) · 15+ boxes or a strength we don’t list? Ask for a bulk price: WhatsApp · Email

Order on WhatsApp instead

Prefer email? Order by email

  • No minimumBoxes of 10 vials
  • Tracked shippingDispatched in 1–2 working days
  • Batch COAFree on request
  • Photographed firstBefore it ships

Purity guarantee and free replacement within 14 days if anything arrives damaged or wrong. How it works

We accept

  • Bank transfer
  • Visa
  • Mastercard
  • American Express
  • PayPal
  • Crypto

Often ordered together

Cagrilintide + Semaglutide (CagriSema) Cagrilintide 2.5 mg + Semaglutide 2.5 mg$99.25 / box
Bacteriostatic Water 3 mL$9.00 / box
2 boxes, 20 vials$108.25

One box of each. Change strengths or quantities in the cart.

Also ordered with Cagrilintide + Semaglutide (CagriSema)

About Cagrilintide + Semaglutide (CagriSema)

What is Cagrilintide + Semaglutide (CagriSema)?

Overview

What is Cagrilintide + Semaglutide (CagriSema)?

This is a research blend of two peptides in one vial: cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 receptor agonist. CagriSema is the name this pairing carries in Novo Nordisk's clinical programme; we use it only to identify the combination, and this preparation is not that company's product. The two peptides act through different hormone systems, which is the case for combining them. Supplied as a lyophilised powder in sealed vials, boxed in tens, for laboratory research use only.

Laboratory research use onlyNobelPepLab supplies Cagrilintide + Semaglutide (CagriSema) strictly for in vitro and laboratory research. We do not provide dosing guidance, do not make health claims, and do not supply products for human or veterinary use.

Cagrilintide + Semaglutide (CagriSema) at a glance

Cagrilintide + Semaglutide (CagriSema) specifications
CompoundCagrilintide + Semaglutide (CagriSema)
Also known asCagriSema, Cagri Sema, Cagri-Sema, cagrilintide semaglutide blend, cagrilintide and semaglutide
ClassificationResearch blend: cagrilintide and semaglutide co-lyophilised in one vial at a 1:1 ratio
Purity99%+ by HPLC
Physical formLyophilised powder
Available strengthsCagrilintide 2.5 mg + Semaglutide 2.5 mg, Cagrilintide 5 mg + Semaglutide 5 mg, Cagrilintide 10 mg + Semaglutide 10 mg
Box quantity10 vials
Price from$9.93 per vial ($99.25 per box)
Research statusThe cagrilintide and semaglutide combination has phase 2 data in type 2 diabetes and phase 3 data in overweight and obesity, both published in major journals. Each component also has its own trial record.
DocumentationBatch-specific third-party COA

These are catalogue target specifications, not batch results. The 99%+ purity figure is the specification we buy to. The authoritative figures for any particular box are the ones printed on that box’s Certificate of Analysis, which is lot-specific. What research grade actually means explains the difference. Terms such as HPLC purity and net peptide content are explained in the peptide glossary.

We make no “third-party verified” claim for a batch unless the matching report is supplied with it. Ask for the current COA for the lot in stock before you order — we will send it.

Prices for every strength

Pricing

How much does Cagrilintide + Semaglutide (CagriSema) cost?

Cagrilintide + Semaglutide (CagriSema) starts at $9.93 per vial (£7.44), sold in boxes of 10 at $99.25. One box is the smallest order and there is no trade account or minimum spend. Larger volumes are negotiable.

Cagrilintide + Semaglutide (CagriSema) price by strength. Billed in USD; GBP shown for reference. Each box contains 10 vials.
StrengthPer vialBox of 10
Cagrilintide 2.5 mg + Semaglutide 2.5 mg$9.93 £7.44$99.25 £74.36
Cagrilintide 5 mg + Semaglutide 5 mg$13.79 £10.33$137.85 £103.28
Cagrilintide 10 mg + Semaglutide 10 mg$16.08 £12.05$160.81 £120.48
Important: Investigational combination, not approved for any use in any country. Not for human consumption.
Storage & reconstitution

Handling

How should Cagrilintide + Semaglutide (CagriSema) be stored and reconstituted?

Sealed vials tolerate ambient temperature in transit and keep at −20 °C beyond that. Reconstitute slowly down the vial wall, swirl rather than shake, then refrigerate at 2–8 °C and aliquot before freezing.

What it is researched for

Research Context

What is Cagrilintide + Semaglutide (CagriSema) researched for?

Below is a plain-English summary of what published research has investigated, and what it has found. These are descriptions of research activity and published results. They are not claims about what Cagrilintide + Semaglutide (CagriSema) does, and nothing here is a statement that it is safe or effective for any purpose.

Research status The cagrilintide and semaglutide combination has phase 2 data in type 2 diabetes and phase 3 data in overweight and obesity, both published in major journals. Each component also has its own trial record.

What the trials found

A phase 2 trial in type 2 diabetes compared the combination with each peptide alone and reported greater reductions in HbA1c and body weight with the combination. A phase 3 trial in adults with overweight or obesity reported greater weight reduction with the combination than with either peptide alone or placebo. 12

Why amylin and GLP-1 are combined

Amylin and GLP-1 reduce food intake through different receptor systems, so pairing them aims at an additive effect without raising the dose of either. The trials above are the test of that rationale. 12

What is not established

Long-term outcome and safety data beyond the trial periods is not yet available. The trials gave the two peptides as a co-administered injection; how a co-lyophilised research blend compares on stability has not been published.

References

  1. 1Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet (2023). PMID 37364590
  2. 2Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. N Engl J Med (2025). PMID 40544433

Links open the record on PubMed or PubMed Central. These are citations to published research, not claims about this product.

Read this before citing any of the abovePreclinical means the work was done in cells or animals. Results in those systems very often fail to reproduce in humans. NobelPepLab supplies Cagrilintide + Semaglutide (CagriSema) for laboratory research only, does not provide dosing guidance, and does not supply products for human or veterinary use.
Laboratory uses

Applications

Where Cagrilintide + Semaglutide (CagriSema) is used in the laboratory

  • Amylin and GLP-1 co-agonism, the pairing that has reached phase 3 as a fixed combination
  • Comparative work against cagrilintide and semaglutide on their own, both stocked separately in this catalogue
  • Dose research at a fixed ratio: all three strengths keep the 1:1 ratio used in the published trials, so the amount changes and the ratio does not
  • Comparison with single-molecule multi-receptor agonists such as tirzepatide and retatrutide
Batch COA

Verification

Does Cagrilintide + Semaglutide (CagriSema) come with a COA?

Yes — every box. Each batch of Cagrilintide + Semaglutide (CagriSema) is analysed by an independent third-party laboratory, and the certificate is tied to the batch number on the vial label.

Example Certificate of Analysis, not the certificate for this batch

Example COA. You receive the certificate matching your own batch.

Questions & answers

Questions

Cagrilintide + Semaglutide (CagriSema) questions, answered

What is CagriSema?

CagriSema is the clinical-programme name for cagrilintide combined with semaglutide. It is not a single molecule: two separate peptides are used together. In our vials the two are co-lyophilised at a 1:1 ratio, and each strength lists the amount of each peptide.

Why buy the blend rather than cagrilintide and semaglutide separately?

The peptides are the same; the difference is preparation. A premixed vial fixes the ratio and means one reconstitution instead of two. Separate vials let you change the ratio. We stock both, so choose the separate peptides if your protocol needs a ratio other than 1:1.

Is CagriSema approved?

No. The combination is investigational and is not approved for any use in any country. Semaglutide on its own is a licensed medicine in some countries, but the research material sold here is not a medicine and is not for human consumption.

How much does Cagrilintide + Semaglutide (CagriSema) cost?

Cagrilintide + Semaglutide (CagriSema) starts at $9.93 per vial, sold in boxes of 10 vials at $99.25 per box (about £74.36). 3 strengths available: Cagrilintide 2.5 mg + Semaglutide 2.5 mg, Cagrilintide 5 mg + Semaglutide 5 mg, Cagrilintide 10 mg + Semaglutide 10 mg. There is no minimum order.

How is Cagrilintide + Semaglutide (CagriSema) shipped to the UK and USA?

Tracked to the UK, USA, EU and worldwide, in plain packaging, dispatched within 1–2 working days. Country-by-country estimates are on the shipping page.